Nuvectis Pharma Inc (NVCT)
Nuvectis Pharma stock today
Nuvectis Pharma closed at $18.48 on October 30, 2026, down 0.48% on the day. Over the past year it returned +178.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $490 million.
| Period | NVCT | S&P 500 (SPY) |
|---|---|---|
| 1 month | -12.5% | -0.9% |
| 3 months | -18.8% | +2.1% |
| Year to date | +144.8% | +11.7% |
| 1 year | +178.3% | +12.4% |
| 3 years | +120.8% | +88.5% |
Key statistics
- Market value
- $490M
- 52-week range
- $5.65 to $28.53
- Next report
- Nov 3, 2026 (estimated)
About Nuvectis Pharma
Nuvectis Pharma is a biopharmaceutical company developing drug treatments.
Sector: Health Care
More on Nuvectis Pharma
- Returns: what $1,000 became$1,000 three years ago is $2,208 today
No forecast, no recommendation. This page describes Nuvectis Pharma Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.